In addition to inhibiting neurodegeneration, HACE1 has been reported to activate the Nrf2/ARE signaling pathway, upregulate HO-1 and NQO1 antioxidant genes, and attenuate H/R-induced oxidative stress and inflammation, making it a promising therapeutic target and predictor of cardiac disease (42). This evidence concerns the gene HACE1 and heart disorder.